PHASE 5.2:



non-gov·ern·ment / HTA

Health technology assessments (HTAs) are typically reserved for innovative health products that are considered to be “disruptive”. Non-disruptive health products often do not require these assessments. It is important to determine a product’s innovation type before proceeding with an HTA.

In Ontario, HTAs are often conducted by non-governing agencies and organizations (CADTH, CHEPA, IC/ES, PATH, THETA) agencies as well as individual innovation centres and hospitals (The Hub at St Michael’s; TASK at SickKids) (see resource list below), and individual innovation centres and hospitals. These agencies and organizations often require a fee for service to conduct an HTA. HTAs performed by these entities inform decisions surrounding health policy and purchasing, service management, and clinical practice. These agencies and organizations include multidisciplinary teams of experts tasked with identifying and synthesizing relevant information to evaluate a new product. To commercialize in Ontario, local HTA entities at the regional and hospital level aim to support decision making for the acquisition, implementation, maintenance, and disinvestment of health care technologies. At the regional and hospital level, HTAs are often used to support hospital-wide decision making and to influence hospital policy and clinical practice. HTAs performed by non-government agencies and organizations also emphasize local budgetary impact and feasibility requirements for adoption.



innovators checklist

  • Determine whether the product is a disruptive or non-disruptive innovation before seeking an HTA.

  • Determine whether the product requires public funding. If no, an HTA performed by a non-government agency/organization is the best pathway.

  • Identify an organization's specific HTA requirements before engaging them.



Last update: 2018-Nov-26

© Copyright 2018 HIIO